- AE (30
December 1965). "Production of High-Potency
Concentrates of
Antihemophilic Globulin in a Closed-Bag System: ****ay in
Vitro and in Vivo". The New...
-
Turoctocog alfa (trade name NovoEight) is a
recombinant antihemophilic factor VIII used for the
treatment of and
prophylaxis of
bleeding patients with...
-
Coagulation factor VIII (Factor VIII, FVIII, also
known as anti-hemophilic
factor (AHF)) is an
essential blood clotting protein. In humans, it is encoded...
-
recombinant antihemophilic factor VIII
Efmoroctocog alfa, a
recombinant antihemophilic factor VIII
Moroctocog alfa, a
recombinant antihemophilic factor VIII...
-
Factor XI, or
plasma thromboplastin antecedent, is the
zymogen form of
factor XIa, one of the
enzymes involved in coagulation. Like many
other coagulation...
-
hemophilia A; it was
identified in the 1950s and is
alternatively called antihemophilic globulin due to its
capability to
correct hemophilia A.
Factor IX was...
- (1953). "Effect of
antihemophilic factor on one-stage
clotting tests; a
presumptive test for
hemophilia and a
simple one-stage
antihemophilic factor ****ay procedure"...
- Cryoprecipitate, also
called cryo for short, or
Cryoprecipitate Antihemophilic factor (AHF), is a
frozen blood product prepared from
blood plasma. To create...
-
hormones (for
treating infertility),
human albumin,
monoclonal antibodies,
antihemophilic factors,
vaccines and many
other drugs.
Mouse hybridomas,
cells fused...
-
approved by the FDA for the US in May 2018.
Adynovate –
PEGylated Antihemophilic Factor VIII for the
treatment of
patients with
hemophilia A. (Baxalta...
